Working from Home has Many Benefits, New Study Confirms

Mark Berkley and Susan Halper Berkley work from home due to COVID-19 restrictions in Maplewood, New Jersey, March 18, 2020. (REUTERS Photo)
Mark Berkley and Susan Halper Berkley work from home due to COVID-19 restrictions in Maplewood, New Jersey, March 18, 2020. (REUTERS Photo)
TT

Working from Home has Many Benefits, New Study Confirms

Mark Berkley and Susan Halper Berkley work from home due to COVID-19 restrictions in Maplewood, New Jersey, March 18, 2020. (REUTERS Photo)
Mark Berkley and Susan Halper Berkley work from home due to COVID-19 restrictions in Maplewood, New Jersey, March 18, 2020. (REUTERS Photo)

Working from home allows people to eat more healthily, feel less stressed and have lower blood pressure, according to a recent study.

The study, led by researchers at the UK Health Security Agency (UKHSA) and King’s College London, considered 1,930 academic papers on home working, teleworking and other types of hybrid work, reported The Guardian.

The team found that working from home allows people to eat more healthily, feel less stressed and have lower blood pressure, as well as making them less likely to take time off sick, tend to work longer hours and to work evenings and weekends.

“The effects of working from home on health were clearer in this study. The transition to home working during Covid was linked with an increase in intake of vegetables, fruit, dairy, snacks, and self-made meals; younger workers and females benefited the most in terms of healthier eating,” the researchers wrote in their paper, which was published in the Journal of Occupational Health.

Most of the reviewed papers also showed that people working from home felt more stable, calmer, and more productive and creative.

Yet, remote workers are also more likely to eat snacks, drink more, smoke more and put on weight, the study found.

Prof. Neil Greenberg, a psychiatrist at King’s College London and one of the study’s authors, said the study showed that workers and employers needed to start considering home working with the same seriousness as they did office working.

Refusing the working from home options will mean that talented employees may find other jobs, and makes companies less flexible in the event of future crises, such as another health emergency or strikes or severe weather conditions that prevent people from reaching their offices, he added.



Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
TT

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights

Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study on Saturday.

Presenting the findings at the European Society of Cardiology annual meeting in London, they said the study showed for the first time that simple blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the next three decades.

"This is good for patients first and foremost, but it is also important information for (manufacturers of) cholesterol lowering drugs, anti-inflammatory drugs, and lipoprotein(a)lowering drugs - the implications for therapy are broad," said study leader Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, Reuters reported.

Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of 5 or 10 year risk."

The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.

They also had tests for high-sensitivity C-reactive protein (hsCRP) - a marker of blood vessel inflammation - and lipoprotein(a), a genetically determined type of fat.

Compared to risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the next 30 years were 36% higher in women with the highest levels of LDL-C, 70% higher in women with the highest levels of hsCRP, and 33% higher in those with the highest levels of lipoprotein(a).

Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the next three decades, according to a report of the study in The New England Journal of Medicine published to coincide with the presentation at the meeting.

“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said.

“The therapies we might use in response to an elevation in each biomarker are markedly different, and physicians can now specifically target the individual person’s biologic problem.”

While drugs that lower LDL-C and hsCRP are widely available - including statins and certain pills for high blood pressure and heart failure - drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis , Amgen , Eli Lilly and London-based Silence Therapeutics.

In some cases, lifestyle changes such as exercising and quitting smoking can be helpful.

Most of the women in the study were white Americans, but the findings would likely “have even greater impact among Black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.

“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”